NCT06407934 · Interventional trial
A Study to Evaluate the Treatment Response and Safety of Two Dose Regimens of Subcutaneous Amlitelimab Compared With Treatment Withdrawal in Participants Aged 12 Years and Older With Moderate-to-severe Atopic Dermatitis
Overall registry status Active not recruiting
Phase 3
Conditions Dermatitis Atopic
Delaware Valley sites
- Clinical Research of Philadelphia- Site Number : 8401193 · Philadelphia, PA · Philadelphia County
- Dermatology Associates of Plymouth Meeting- Site Number : 8401147 · Plymouth Meeting, PA · Montgomery County
- Paddington Testing Company- Site Number : 8401041 · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory